For citations:
Stoma I.O., Voropaev E.V., Mikhailova E.I., Korsak K.S., Osipkina O.V., Molchanova A.V., Kovalev A.A., Los D.M., Ziatskov A.A., Shaforost A.S., Yatsuk M.N., Braga A.Yu., Trofimova N.V., Dronina A.M., Gasich E.L., Gorbunov V.A., Hancharou A.E. Evaluation of Immunogenicity of Inactivated Whole-Virion Booster Vaccine against SARS-CoV-2 in a phase I, II Clinical Trial. Epidemiology and Vaccinal Prevention. 2024;23(6):61-72. (In Russ.) https://doi.org/10.31631/2073-3046-2024-23-6-61-72
Email this article 